全球左心耳封堵器市場規模、佔有率和成長分析：按產品、程序、最終用途 - 產業預測（2024-2031）

Global Left Atrial Appendage Closure Devices Market Size, Share, Growth Analysis, By Product, By Procedure, By End - Use - Industry Forecast 2024-2031

出版日期: 2024年03月03日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年，全球左心耳封堵器市場規模將達到12.1億美元，從2023年的14.6億美元擴大到2031年的64.8億美元，並將在預測期內持續成長（2024年-2031年)預計複合年成長率為20.5%。

心房顫動（一種心臟病）病例數量的增加與不健康的飲食習慣、吸煙和缺乏運動有關。生活方式的改變、獲得醫療保健的便利性以及面臨心臟病風險的老年人數量不斷增加也影響了治療需求的增加。先進技術在心律相關手術的使用也在增加，提高了安全性和有效性，使已開發國家和開發中國家都受益。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Boston Scientific Corporation（USA）
Abbott Laboratories（USA）
AtriCure, Inc.（USA）
Johnson & Johnson（USA）
Lifetech Scientific（China）
Occlutech International AB（Sweden）
Artio Medical（USA）
Cardia, Inc.（USA）
SentreHEART, Inc.（USA）
Lepu Medical Technology Co., Ltd.（China）

簡介目錄

Product Code: SQMIG35A2586

Global Left Atrial Appendage Closure Devices Market size was valued at USD 1.21 billion in 2022 and is poised to grow from USD 1.46 billion in 2023 to USD 6.48 billion by 2031, growing at a CAGR of 20.5% in the forecast period (2024-2031).

The rise in cases of atrial fibrillation, a heart condition, is connected to things like unhealthy diets, smoking, and lack of exercise. This increase in demand for treatment is also influenced by changes in how we live, easier access to healthcare, and more older people who are at risk of heart problems. There's also a growing opportunity in using advanced technology for procedures related to heart rhythm, which has improved safety and effectiveness, benefiting both developed and developing countries.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Left Atrial Appendage Closure Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Left Atrial Appendage Closure Devices Market Segmental Analysis

The global left atrial appendage closure devices market is segmented on the basis of product, procedure, end use, and region. By product, the market is segmented into endocardial LAA devices, epicardial LAA devices. By procedure, the market is segmented into percutaneous, surgical. By end - use, the market is segmented into hospitals, ambulatory surgical centers, and others. By region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.

Drivers of the Global Left Atrial Appendage Closure Devices Market

The rising number of people with atrial fibrillation, which increases the risk of stroke and heart problems, is a big reason why more left atrial appendage (LAA) closure devices are being used.

Restraints in the Global Left Atrial Appendage Closure Devices Market

Strict regulations for approving medical devices can delay the release of new products and restrict access to LAA closure devices in some markets.

Market Trends of the Global Left Atrial Appendage Closure Devices Market

The move toward less invasive treatments is causing a shift away from open-heart surgeries to minimally invasive procedures for closing the left atrial appendage (LAA). This change means patients have shorter recovery times and spend less time in the hospital.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Left Atrial Appendage Closure Devices Market by Product

Market Overview
Endocardial LAA Devices
Epicardial LAA Devices

Global Left Atrial Appendage Closure Devices Market by Procedure

Market Overview
Percutaneous
Surgical

Global Left Atrial Appendage Closure Devices Market by End - Use

Market Overview
Hospitals
Ambulatory Surgical Centers
Others

Global Left Atrial Appendage Closure Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AtriCure, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lifetech Scientific (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Occlutech International AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Artio Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardia, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SentreHEART, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lepu Medical Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments